April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Inter/Intra-Observer Agreement to Detect Glaucomatous Visual Field Progression by Using Standard Humphrey Printout, Glaucoma Progression Analysis 1 and 2
Author Affiliations & Notes
  • M. M. Iester
    Neurolog Sci & Ophthal Genetic, University Eye Clinic, Genova, Italy
  • E. Capris
    Neurolog Sci & Ophthal Genetic, University Eye Clinic, Genova, Italy
  • F. De Feo
    Neurolog Sci & Ophthal Genetic, University Eye Clinic, Genova, Italy
  • P. Brusini
    Div. Oculistica, Udine, Italy
  • G. Corallo
    Neurolog Sci & Ophthal Genetic, University Eye Clinic, Genova, Italy
  • M. Figus
    Ophthalmology, University of Pisa, Pietrasanta, Italy
  • P. Fogagnolo
    Fondazione GB Bietti-IRCCS, Canegrate Milan, Italy
  • P. Frezzotti
    Ophthal & Neurosurgery, University of Siena, Siena, Italy
  • G. Manni
    Biopatol Diagn Immagini, Univ of Rome Tor Vergata, Rome, Italy
  • A. Perdicchi
    Ospedale Sant Andrea, Univ of Rome La Sapienza II, Rome, Italy
  • Footnotes
    Commercial Relationships  M.M. Iester, None; E. Capris, None; F. De Feo, None; P. Brusini, None; G. Corallo, None; M. Figus, None; P. Fogagnolo, None; P. Frezzotti, None; G. Manni, None; A. Perdicchi, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5501. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. M. Iester, E. Capris, F. De Feo, P. Brusini, G. Corallo, M. Figus, P. Fogagnolo, P. Frezzotti, G. Manni, A. Perdicchi; Inter/Intra-Observer Agreement to Detect Glaucomatous Visual Field Progression by Using Standard Humphrey Printout, Glaucoma Progression Analysis 1 and 2. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5501.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To examine the level of agreement between clinicians in assessing progressive deterioration in visual field series using standard Humphrey printout (SHP), glaucoma progression analysis 1 (GPA) and 2 (GPA2).

Methods: : Each visual field was assessed by Humphrey Field Analyzer (HFA), program SITA standard 30-2 or 24-2 (Carl Zeiss Meditec, Inc., Dublin, CA). Mean Deviation (MD) and Pattern Standard Deviation were considered at baseline and in the end of the follow-up. The first 3 fields in each series were exclude to minimize learning effects: the forth and fifth Full Threshold or SITA Standard exams were used as baseline. Eight expert clinicians assessed the progression status of each series using SHP, GPA and GPA2. The progression criteria adopted by the clinicians were similar to the GPA algorithm comparing single field printout with the baseline exams. The intra and inter observer agreement was evaluated using a weighted kappa statistic. The Κ statistic was calculated interpreting as Κ<0 indicating no agreement; Κ = 0.0 to 0.19, poor; Κ = 0.20 to 0.39, fair; Κ = 0.40 to 0.59, moderate; and Κ = 0.60 to 0.79, substantial; and Κ = 0.80 to 1.0, almost perfect agreement.

Results: : Forty visual field series were analyzed by the 8 physicians. The mean follow-up time was 6.2 + 1.53 years (mean + standard deviation). At baseline the mean MD was -7.34 + 7.18 dB and at the end of the follow-up the mean MD was -9.25 + 8.65 dB, this difference was statistically significant (p<0.001). When the mean intra-observer agreement was 0.57 + 0.14 between SHP and GPA, 0.56 + 0.05 between SHT and GPA2 and 0.54 + 0.17 between GPA and GPA2. When the mean inter-observer agreement was 0.66 + 0.12 for SHP, 0.52 + 0.16 for GPA and 0.69 + 014 for GPA2. The best interobserver agreement was obtained for GPA 2 and the worst was for GPA.

Conclusions: : Intra-observer agreement was good for the three different methods to assess VF progression, GPA2 had the best interobserver agreement.

Keywords: perimetry • visual fields 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×